Recently Approved and Upcoming Treatments for Narcolepsy

Narcolepsy is a chronic, disabling neurologic disorder characterised by excessive daytime sleepiness (EDS) and, in up to 60% of patients, cataplexy. Treatments for narcolepsy are aimed at improving wakefulness (e.g. modafinil, armodafinil, stimulants), reducing cataplexy attacks (e.g. sodium oxybate...

Descripción completa

Detalles Bibliográficos
Autor principal: Thorpy, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982634/
https://www.ncbi.nlm.nih.gov/pubmed/31953791
http://dx.doi.org/10.1007/s40263-019-00689-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982634/
https://www.ncbi.nlm.nih.gov/pubmed/31953791
http://dx.doi.org/10.1007/s40263-019-00689-1

Ejemplares similares